Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen

ClinicalTrials.gov ID: NCT03974932

Public ClinicalTrials.gov record NCT03974932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 7:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Open-Label Study of HTX-011 as Part of a Scheduled Non-Opioid Multimodal Analgesic Regimen in Subjects Undergoing Total Knee Arthroplasty

Study identification

NCT ID
NCT03974932
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Heron Therapeutics
Industry
Enrollment
116 participants

Conditions and interventions

Conditions

Interventions

  • HTX-011 Drug
  • Ibuprofen Drug
  • Acetaminophen Drug
  • Celecoxib Drug
  • +/- Bupivacaine HCl Drug
  • Luer Lock Applicator Device

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 4, 2019
Primary completion
Dec 6, 2020
Completion
Jan 6, 2021
Last update posted
Mar 1, 2026

2019 – 2021

United States locations

U.S. sites
6
U.S. states
4
U.S. cities
6
Facility City State ZIP Site status
Helen Keller Hospital Sheffield Alabama 35660
Phoenix Clinical Research, LLC Tamarac Florida 33321
Midwest Clinical Research Center, LLC Dayton Ohio 45417
First Surgical Hospital Bellaire Texas 77401
Plano Surgical Hospital Plano Texas 75093
Endeavor Clinical Trials, LLC. San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03974932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2026 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03974932 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →